Welcome to LookChem.com Sign In|Join Free
  • or
N-(2-carbamoylphenyl)-2-methoxybenzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

51759-65-0

Post Buying Request

51759-65-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51759-65-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 51759-65-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,7,5 and 9 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 51759-65:
(7*5)+(6*1)+(5*7)+(4*5)+(3*9)+(2*6)+(1*5)=140
140 % 10 = 0
So 51759-65-0 is a valid CAS Registry Number.

51759-65-0Relevant academic research and scientific papers

Competing HB acceptors: An extensive NMR investigations corroborated by single crystal XRD and DFT calculations

Tiwari, Surbhi,Arya, Neeru,Mishra, Sandeep Kumar,Suryaprakash

, p. 15195 - 15202 (2021/05/21)

A series of N-benzoylanthranilamide derivatives have been synthesized with the substitution of competitive HB acceptors and investigated by NMR spectroscopy and single crystal XRD. The interesting rivalry for HB acceptance between CO and X (F or OMe) is observed in the investigated molecules which leads to an unusual increase in the electron density at the site of one of the NH protons, reflecting in the high field resonance in the 1H NMR spectrum. The NMR experimental findings and single crystal XRD are further reinforced by the DFT studies.

TREATING LONG QT SYNDROME

-

Page/Page column 38, (2020/08/22)

This document relates to compounds useful for treating and preventing disorders associated with long QT syndrome such as cardiac arrhythmia, ventricular arrhythmia, hypertrophic cardiomyopathy, and congestive heart failure. Also provided herein are methods and materials for using such compounds to shorten myocardial repolarization time in a patient.

Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands

Jiang, Yin,Chen, Ai-Chun,Kuang, Guo-Tao,Wang, Shi-Ke,Ou, Tian-Miao,Tan, Jia-Heng,Li, Ding,Huang, Zhi-Shu

, p. 264 - 279 (2016/07/07)

A series of 4-anilinoquinazoline derivatives were designed and synthesized as novel c-myc promoter G-quadruplex binding ligands. Subsequent biophysical and biochemical evaluation demonstrated that the introduction of aniline group at 4-position of quinazoline ring and two side chains with terminal amino group improved their binding affinity and stabilizing ability to G-quadruplex DNA. RT-PCR assay and Western blot showed that compound 7a could down-regulate transcription and expression of c-myc gene in Hela cells, which was consistent with the behavior of an effective G-quadruplex ligand targeting c-myc oncogene. More importantly, RTCA and colony formation assays indicated that 7a obviously inhibited Hela cells proliferation, without influence on normal primary cultured mouse mesangial cells. Flow cytometric assays suggested that 7a induced Hela cells to arrest in G0/G1 phase both in a time-dependent and dose-dependent manner.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 51759-65-0